San Francisco, CA-based Harvest Capital Strategies has raised $245m for the Harvest Intrexon Enterprise Fund, an investment vehicle dedicated to funding companies that utilize the inventions, discoveries and technologies of Intrexon Corporation (NYSE: XON), a leader in synthetic biology.
The Harvest Intrexon Enterprise Fund will invest exclusively in entities that utilize Intrexon’s technology, with a particular focus on new companies, to spur the creation of biologically-based products across a number of sectors, which may include healthcare, food, agriculture, energy, environment, chemicals and consumer products.
The fund has already made two investments to date:
– Thrive Agrobiotics, Inc., a startup entity formed to utilize Intrexon’s ActoBiotics® platform to express nutritive proteins for improving the overall growth and feed efficiency in piglets, and
– Intrexon Energy Partners II, a joint venture formed to utilize Intrexon’s proprietary gas-to-liquids platform to produce 1,4 butanediol, a chemical intermediate used to manufacture spandex, polyurethane and plastics from low-cost natural gas feedstock.
Harvest Capital Strategies is the investment arm of JMP Group LLC, an investment banking and alternative asset management firm providing investment banking, equity research, and sales and trading services to corporate and institutional clients as well as alternative asset management products and services to institutional and high-net-worth investors.